M Maral Mouradian

12PUBLICATIONS
46CO-AUTHORS
Neurology and neuromuscular diseasesToxicology (incl. clinical toxicology)TransgenesisPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 01, 2026
Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-Associated Parkinson's Disease.

|Mar 25, 2026
Protein phosphatase 2A methylation state impacts α-synucleinopathy in mouse models.

Santhosh Maddila, Kambiz Hassanzadeh, Jun Liu

|Mar 19, 2026
The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy models.

Kambiz Hassanzadeh, Jun Liu, Jie Zhang

|Jul 10, 2025
Disease-Modifying Trials in Treated Parkinson's Disease: "Stable Treated" Does Not Equate with Biological Stability.

M Maral Mouradian, A Jon Stoessl, Anthony E Lang

|Jan 05, 2024
Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera.

Yuquan Tong, Peiyuan Zhang, Xueyi Yang

Pageof 2